多剤耐性病原体に対抗する細菌の小さなRNAの応用に関する最新の知見

Ayenewら（Wed,）はこの問題を研究しました。

www.synapsesocial.com/papers/69a75cacc6e9836116a25bbd — DOI: https://doi.org/10.1016/j.sciaf.2026.e03212

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Recent Advances in Nanoparticle-Mediated siRNA Delivery· 2014 · 154 citations
2. Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities· 2022 · 56 citations
3. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis· 2022 · 15,092 citations
4. Emerging Concern with Imminent Therapeutic Strategies for Treating Resistance in Biofilm